JAN 24, 2019 11:46 PM PST

Why Do Promising Cancer Drugs Fail?

WRITTEN BY: Nouran Amin

After almost 20 years of a once-promising cancer drugs known as MMP inhibitors suddenly failed in clinical trials, scientists are now eager to provide an explanation.

MMP inhibitors, known as matrix metalloproteinases, originally work by targeting enzymes thought to be responsible for the spread of cancer. The results in the model C. elegans worms can lead to more effective ways to prevent the initial steps of metastasis, in what results in about 90 percent of all tumor-related deaths.

Learn more about MMPs in cancer metastasis:

Despite the promising results of MMP inhibitors in mice, they were not successful in people with some patients developing serious side effects. New findings suggest that maybe cancerous cells will convert themselves to a brute force when no dissolving enzymes are available. Findings were published in Developmental Cell.

Caption: This image shows the uncontrolled growth of cells in squamous cell carcinoma.

Credit: Markus Schober and Elaine Fuchs, The Rockefeller University, New York via NIH

The study suggested that the reason why MMPs did not work on human tumors is because--“Normal worm cells use their MMP enzymes to help cut through the matrix of proteins in the basement membrane like molecular scissors, the researchers say. But cells in "knockout" worms lacking the MMP enzymes instead build a large protrusion that pummels and smashes its way through with brute force,” said experimental leader and research scientist,” Laura Kelley.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 13, 2019
Drug Discovery & Development
OCT 13, 2019
Controlling The Release of Drug Components Using Artificial DNA
Studies carried out at the Technical University of Munich (TUM) can allow nanapoarticles to be released in pre-defined sequence at specified times. Using a...
OCT 13, 2019
Chemistry & Physics
OCT 13, 2019
Chemists Synthesized Effective Antidote For Uranium Poisoning
Uranium poisoning is unusual to the general population but does happen to miners, mineral mill and fabrication workers. Through inhaling and ingestion, ura...
OCT 13, 2019
Technology
OCT 13, 2019
Computer Model Advances New Therapeutics for Sickle Cell Anemia
A team of Brown University researchers has developed a new computer model that simulates the way red blood cells become misshapen by sickle cell anemia. A ...
OCT 13, 2019
Drug Discovery & Development
OCT 13, 2019
Standard Treatment Resistance Discovered in Crohn's Disease
Researchers have mapped out more than 100,000 immune cells from biopsy samples of patients with Crohn's disease. The biopsy samples were retrieved from...
OCT 13, 2019
Neuroscience
OCT 13, 2019
Can CRISPR Technology Treat Alzheimer's?
New drugs that seek to treat Alzheimer’s disease (AD) have a 99.6% failure rate. This makes it the only disease in the top 10 causes of death that ca...
OCT 13, 2019
Genetics & Genomics
OCT 13, 2019
Gene-Editing Breakthrough for Cervical Cancer
Researchers at the The Menzies Health Institute Queensland have found a way to use gene therapy CRISPR-Cas9 to treat cervical cancer. The first treatment o...
Loading Comments...